Amporin Pharmaceuticals AG is a Swiss biotechnology company founded in Basel in 2024. The firm focuses on developing a new class of small-molecule drugs designed to target toxic…
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Amporin Pharmaceuticals →Already a subscriber? Sign in
Xcout Intel tracks Amporin Pharmaceuticals continuously — this profile deepens as new filings, funding, people and hiring data arrive.